Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
Search by expertise, name or affiliation
Randomized Double Blind Placebo Controlled Multicent Phase III Study of Rosuvastatin (CRESTOR) 20 mg in the Primary Prevention of Cardiovascular Events Among Subjects
Anderson, James
(PI)
Reynolds, L
(CoI)
Tannock, Lisa
(CoI)
Internal Medicine
Overview
Grants and Contracts Details
Status
Finished
Effective start/end date
1/1/05
→
12/31/06
Funding
AstraZeneca Pharmaceuticals AB:
$15,830.00
View all
View less